These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 11550020

  • 1. Role of I(1)-imidazoline receptors and alpha2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla.
    Khokhlova ON, Murashev AN, Medvedev OS.
    Bull Exp Biol Med; 2001 Apr; 131(4):336-9. PubMed ID: 11550020
    [Abstract] [Full Text] [Related]

  • 2. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA, Dreshaj I, Schäfer SG, Ernsberger P.
    J Cardiovasc Pharmacol; 1994 Apr; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C, Niederhoffer N, Szabo B.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [Abstract] [Full Text] [Related]

  • 4. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
    Tolentino-Silva FP, Haxhiu MA, Waldbaum S, Dreshaj IA, Ernsberger P.
    Brain Res; 2000 Apr 17; 862(1-2):26-35. PubMed ID: 10799665
    [Abstract] [Full Text] [Related]

  • 5. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X, Li G, Abdel-Rahman AA.
    Eur J Pharmacol; 2005 May 09; 514(2-3):191-9. PubMed ID: 15910806
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S, Menaouar A, Gutkowska J.
    Eur J Pharmacol; 2006 Jul 10; 541(1-2):73-9. PubMed ID: 16774751
    [Abstract] [Full Text] [Related]

  • 10. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS, Takakura AC, Menani JV, Colombari E.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):164-71. PubMed ID: 17382316
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
    Ziegler D, Haxhiu MA, Kaan EC, Papp JG, Ernsberger P.
    J Cardiovasc Pharmacol; 1996 Jun 01; 27 Suppl 3():S26-37. PubMed ID: 8872297
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low dose of moxonidine within the rostral ventrolateral medulla improves the baroreflex sensitivity control of sympathetic activity in hypertensive rat.
    Wang JL, Wang L, Wu ZT, Yuan WJ, Su DF, Ni X, Yan JJ, Wang WZ.
    Acta Pharmacol Sin; 2009 Dec 01; 30(12):1594-600. PubMed ID: 19960005
    [Abstract] [Full Text] [Related]

  • 15. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG, Kaan EC, Christen MO, Löw-Kröger A, Mest HJ, Molderings GJ.
    Ann N Y Acad Sci; 1995 Jul 12; 763():659-72. PubMed ID: 7677385
    [Abstract] [Full Text] [Related]

  • 16. Commissural nucleus of the solitary tract regulates the antihypertensive effects elicited by moxonidine.
    Totola LT, Alves TB, Takakura AC, Ferreira-Neto HC, Antunes VR, Menani JV, Colombari E, Moreira TS.
    Neuroscience; 2013 Oct 10; 250():80-91. PubMed ID: 23850502
    [Abstract] [Full Text] [Related]

  • 17. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ, Lapp CA, Westbrooks KL, Ernsberger P.
    J Pharmacol Exp Ther; 1995 Jun 10; 273(3):1162-71. PubMed ID: 7791087
    [Abstract] [Full Text] [Related]

  • 18. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
    Cao C, Kang CW, Kim SZ, Kim SH.
    Am J Physiol Heart Circ Physiol; 2004 Jul 10; 287(1):H150-6. PubMed ID: 14975931
    [Abstract] [Full Text] [Related]

  • 19. Sympathoexcitation of moxonidine in the caudal ventrolateral medulla is dependent on I1-imidazoline receptors in anesthetized rats.
    Wang LG, Gao L, Wang W, Yuan WJ, Wang WZ.
    Neurosci Lett; 2007 Oct 16; 426(2):91-6. PubMed ID: 17889438
    [Abstract] [Full Text] [Related]

  • 20. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
    Parkin ML, Godwin SJ, Head GA.
    J Hypertens; 2003 Jan 16; 21(1):167-78. PubMed ID: 12544449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.